Home - Products - Others - Other Targets - Picropodophyllin 4-O-β-D-glucoside

Picropodophyllin 4-O-β-D-glucoside

CAS No. 1400-92-6

Picropodophyllin 4-O-β-D-glucoside( ——— )

Catalog No. M38353 CAS No. 1400-92-6

Picropodophyllin-β-D-glucoside (compound 3) is a podophyllotoxin glucoside isolated from Chinese medicinal plants.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Picropodophyllin 4-O-β-D-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Picropodophyllin-β-D-glucoside (compound 3) is a podophyllotoxin glucoside isolated from Chinese medicinal plants.
  • Description
    Picropodophyllin-β-D-glucoside (compound 3) is a podophyllotoxin glucoside isolated from Chinese medicinal plants.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1400-92-6
  • Formula Weight
    576.55
  • Molecular Formula
    C28H32O13
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhao C, et al. New lignan glycosides from Chinese medicinal plant, Sinopodophillum emodiJ. Chemical and pharmaceutical bulletin, 2003, 51(3): 255-261.
molnova catalog
related products
  • EN106

    EN106 is a potent inhibitor of FEMIB and is a cysteine-reactive covalent ligand. EN106 disrupts recognition of the key reductive stress substrate of FEM1B, FNIP1.

  • S16961

    S16961 is an agonist of nicotinic receptor.

  • Chicanine

    Chicanine has anti-inflammatory activity in macrophages by down-regulating LPS-induced inflammatory cytokines in IκBα±/MAPK/ERK signaling pathways.